| Literature DB >> 23390403 |
Abstract
Health plans understand that it is more cost-effective to administer infused therapies in an ambulatory setting than in a hospital. Some physician groups might view in-house infusion centers as a financial opportunity, but should carefully weigh the steep risks involved before jumping in.Year: 2005 PMID: 23390403 PMCID: PMC3564322
Source DB: PubMed Journal: Biotechnol Healthc ISSN: 1554-169X